CWHM-12|>98%|abs810092-爱必信(上海)生物科技有限公司

CWHM-12

参考价：¥1733

供货周期：

一周

品牌：

爱必信

规格：

>98%

货号：

abs810092

CAS号：

1564286-55-0

产品详情

公告提醒：爱必信所有产品和服务仅用于科学研究，不用于临床应用及其他用途提供产品和服务（也不为任何个人提供产品和服务）!

抑制剂描述：

产品名称：CWHM-12

产品别名：见爱必信官网

英文别名：CWHM-12

靶点：Integrin

CAS：1564286-55-0

纯度：>98%

外观：见爱必信官网

保存方法：store at -20℃ for one year（Powder）； in DMSO or others solvent store at 2-4℃ for two weeks, at -20℃ for six months.

描述：

CWHM-12 a novel small molecule inhibitor of αV integrins with IC50s of 1.8/0.8/1.5/0.2 nM for αvβ1/αvβ3/αvβ8; less potency on αvβ5(IC50=61 nM) and on inhibition on αIIbβ3/α2β1/α10β1.

溶解性：DMSO: 10.5 mg/mL

体外研究：

CWHM-12 (CWHM 12) also less potently inhibits αvβ5 (IC50=61 nM) and αIIbβ3/α2β1/α10β1 (IC50>5000 nM). CWHM-12 demonstrates high potency against all of the five possible β subunit binding partners (αvβ1, αvβ3, αvβ5, αvβ6 and αvβ8) in in vitro ligand-binding assays, with somewhat less potency against αvβ5 than against the other αv integrins.

体内研究：Mice are treated with CCl4 for 3 weeks to establish fibrotic disease and then treated with CWHM-12 (CWHM 12) or vehicle for the final 3 weeks of CCl4. CWHM-12 significantly reduces liver fibrosis even after fibrotic disease have been established. Digital image quantitation demonstrates significantly reduced p-SMAD3 signaling in the livers of CWHM-12 treated mice compare to controls, demonstrating that the protection from CCl4-induced hepatic fibrosis observed in CWHM-12 treated mice is due at least in part to a reduction in TGF-β activation by αv integrins. Besides, administration of CWHM-12 significantly inhibited progression of pulmonary fibrosis.

产品信息订购：

产品货号	产品名称	规格	价格	大包装及货期
abs810092	CWHM-12	5mg	1733.00	立即咨询
abs810092	CWHM-12	10mg	2830.00	立即咨询
abs810092	CWHM-12	50mg	10319.00	立即咨询
abs810092	CWHM-12	100mg	14742.00	立即咨询

产品更多信息请进入爱必信网站咨询